Partillion Bioscience Receives $2.1 Million NIH Grant for Cell Sequencing

Partillion Bioscience has announced the receipt of a $2.1 million grant from the National Institutes of Health (NIH) Small Business Innovation Research (SBIR) program. The funding will support the development of the company's Cell-Cell-seq workflows, which aim to enable large-scale sequencing of interactions between cells.

This award marks the tenth SBIR grant received by Partillion, bringing the company's total non-dilutive federal funding to over $8 million. The new grant is intended to enhance the understanding of the mechanisms underlying cell-to-cell communication at a granular level.

The technology is designed to assist researchers in identifying and analyzing intercellular signaling pathways. These pathways are crucial in various biological processes, including cancer development and immune responses. Partillion aims to make this analysis more efficient and scalable for scientific study.

The company stated that the grant will significantly contribute to advancing its objectives in the biotechnology sector. The funding is expected to accelerate the development of novel therapeutic strategies based on a deeper comprehension of cell interactions.